Weighing Up the Genetic Risk of Lung Cancer
Investigating rare genetic variants’ contribution to lung cancer susceptibility
Olivia Gaskill | | Quick Read
Researchers have previously investigated risk genes for lung cancer – but we still don’t fully understand how these genes contribute to an individual’s likelihood of the disease. Now, a team at Baylor College of Medicine have used whole exome sequencing and targeted sequencing on high-risk lung cancer cases with the highest genetic predisposition to the disease – for example, early onset or family history of lung cancer (1).
They identified 25 rare deleterious variants associated with an increased risk of lung cancer. Five variants were validated, two of which mapped to genes with a known association with lung cancer susceptibility (ATM and MPZL2) and three to novel susceptibility genes (POMC, STAU2, and MLNR).
Endogenous DNA damage assays further supported the genes’ role in lung cancer susceptibility. “We found that dysregulation or mutations in these candidate genes showed increased DNA damage, suggesting that their potential cancer-causing role might be due to genome instability at the DNA level,” said Jun Xia, co-first author of the study (2).
Subscribe to The Pathologist Newsletters
- Y Liu et al., NPJ Precis Oncol, 5, 12 (2021). PMID: 33594163.
- M Chiu (2021). Available at: https://bit.ly/3nbjcLD.